Genmab A/S (GMAB) Q4 2022 Results Conference Call February 22, 2023 12:00 PM ET Company Participants Jan van de Winkel - President and Chief Executive Officer Anthony Pagano - Chief Financial Officer Judith Klimovsky - Chief Development Officer Anthony Mancini - Chief Operating Officer Tahamtan Ahmadi - Chief Medical Officer Conference Call Participants Matthew Harrison - Morgan Stanley Peter Verdult - Citigroup Sachin Jain - Bank of America Jonathan Chang - SVB Securities Elizabeth Walton - Crédit Suisse A ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F ◻ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ⌧ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal y ear ended December 31, 2022 OR ◻ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period fro m to OR ◻ SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR ...

Exhibit 99.1 GENMAB 2022 ANNUAL REPORT Table of Contents MANAGEMENT’S REVIEW Our Vision 2 Chair’s Statement 2 Letter from the CEO 3 2022 at a Glance 4 Consolidated Key Figures 6 2023 Outlook 9 Our Strategy 11 Who We Are 13 Business Model 14 Research and Development Capabilities 15 Enhancing Commercialization Capabilities to Bring Our Innovations to Patients 16 Antibody Discovery and Development 17 Products and Technologies 17 Corporate Social Responsibility and Sustainability Commitments 37 Genmab’s Task Fo ...

Quarter End Results Period Ended September 30, 2022 Forward looking statement This presentation contains forward looking statements. The words "believe", "expect", "anticipate", "intend" and "plan" and similar expressions identify forward looking statements. All statements other than statements of historical facts included in this presentation, including, without limitation, those regarding our financial position, business strategy, plans and objectives of management for future operations (including develop ...

Genmab A/S (GMAB) Q3 2022 Earnings Conference Call November 9, 2022 12:00 PM ET Company Participants Jan van de Winkel – Chief Executive Officer Anthony Pagano – Chief Financial Officer Tahi Ahmadi – Chief Medical Officer Conference Call Participants Wimal Kapadia – Bernstein Jonathan Chang – SVB Securities Peter Verdult – Citi Paul Jeng – Guggenheim Partners Peter Welford – Jefferies Emily Field – Barclays Elizabeth Walton – Credit Suisse Michael Novod – Nordea Asthika Goonewardene – Truist Securities Zoe ...

Genmab A/S (GMAB) Q2 2022 Results Conference Call August 10, 2022 12:00 PM ET Company Participants Jan van de Winkel - President and CEO Anthony Pagano - CFO Judith Klimovsky - Chief Development Officer Anthony Mancini - COO Tahi Ahmadi - Chief Medical Officer Conference Call Participants Wimal Kapadia - Bernstein Jonathan Chang - SVB Sachin Jain - Bank of America Asthika Goonewardene - Truist Securities James Gordon - JP Morgan Paul Jeng - Guggenheim Securities Elizabeth Walton - Credit Suisse Zoe Karamano ...

Quarter End Results Period Ended March 31, 2022 Forward looking statement This presentation contains forward looking statements. The words "believe", "expect", "anticipate", "intend" and "plan" and similar expressions identify forward looking statements. All statements other than statements of historical facts included in this presentation, including, without limitation, those regarding our financial position, business strategy, plans and objectives of management for future operations (including development ...

Genmab A/S (GMAB) Q1 2022 Earning Conference Call May 11, 2022 12:00 PM ET Company Participants Jan van de Winkel - President and Chief Executive Officer Anthony Pagano - Chief Financial Officer Conference Call Participants Peter Virgil - Citigroup James Gordon - JPMorgan Wimal Kapadia - Bernstein Peter Welford - Jefferies Michael Schmidt - Guggenheim Securities Asthika Goonewardene - Truist Securities Xian Deng - Berenberg Charlie Yang - Morgan Stanley Yaron Werber - Cowen & Co. Operator Hello, and welcome ...

Year End Results Period Ended December 31, 2021 Forward looking statement This presentation contains forward looking statements. The words "believe", "expect", "anticipate", "intend" and "plan" and similar expressions identify forward looking statements. All statements other than statements of historical facts included in this presentation, including, without limitation, those regarding our financial position, business strategy, plans and objectives of management for future operations (including development ...

Genmab A/S (GMAB) Q4 2021 Earnings Conference Call February 16, 2022 12:00 PM ET Company Participants Jan van de Winkel – President and Chief Executive Officer Anthony Pagano – Chief Financial Officer Anthony Mancini – Chief Operation Officer Tahi Ahmadi – Chief Medical Officer Conference Call Participants Wimal Kapadia – Bernstein James Gordon – JP Morgan Kennen MacKay – RBC Paul – Guggenheim Securities Elizabeth Walton – Credit Suisse Peter Virgil – Citi Asthika Goonewardene – Truist Securities Peter Welf ...